Levothyroxine Sodium Tablet
Product Images NDC 31722-288

Product Visual Gallery

This gallery contains 32 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 31722-288). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100-mcg-1000s (100 Mcg 1000s)

Label for LEVOTHYROXINE SODIUM Tablets, USP 100 mcg (0.1 mg), oral tablets, packaged by Camber Pharmaceuticals, Inc. The label shows a 1000 tablet count, with prescription-only designation (Rx Only). It includes storage instructions, manufacturer details (Ascent Pharmaceuticals, Inc.), and notes about dispensing and tablet contents.*

FDA Label Image

100-mcg-90s (100 Mcg 90s)

Label for Levothyroxine Sodium Tablets, USP 100 mcg (0.1 mg) by Camber Pharmaceuticals, Inc. The label shows 90 tablets, Rx only. It includes storage instructions, manufacturer details (Ascent Pharmaceuticals, Inc. and Camber Pharmaceuticals, Inc.), and dosage strength. The label features a barcode and revision date 01/23.*

FDA Label Image

112-mcg-1000s (112 Mcg 1000s)

Label for Levothyroxine Sodium Tablets, USP 112 mcg (0.112 mg) by Camber Pharmaceuticals, Inc. The label shows an NDC number 31722-289-10 and indicates a package count of 1000 tablets for oral administration. Storage and handling instructions are included, along with manufacturer and labeler details.*

FDA Label Image

112-mcg-90s (112 Mcg 90s)

Label for Levothyroxine Sodium Tablets USP 112 mcg (0.112 mg) oral tablets by Camber Pharmaceuticals, Inc. The label indicates a package of 90 tablets with Rx only status. It includes storage instructions, manufacturer and labeler information, and a barcode on a white background with black text and a highlighted pink box around the strength.*

FDA Label Image

125-mcg-1000s (125 Mcg 1000s)

Label for Levothyroxine Sodium Tablets, USP 125 mcg (0.125 mg) by Camber Pharmaceuticals, Inc. The label shows a barcode, NDC 31722-290-10, and indicates the package contains 1000 oral tablets. The label provides storage instructions and manufacturer information for Ascent Pharmaceuticals, Inc. and Camber Pharmaceuticals, Inc.*

FDA Label Image

125-mcg-90s (125 Mcg 90s)

Label for Levothyroxine Sodium Tablets, USP 125 mcg (0.125 mg) by Camber Pharmaceuticals, Inc. The label states 90 tablets, prescription only. It includes storage instructions, dosage mention to see full prescribing info, and manufacturer details for Ascent Pharmaceuticals, Inc. and Camber Pharmaceuticals, Inc. Barcode and NDC 31722-290-90 are visible.*

FDA Label Image

137-mcg-1000s (137 Mcg 1000s)

Label for Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg) oral tablets by Camber Pharmaceuticals, Inc. The package contains 1000 tablets, prescription only. The label includes storage instructions, manufacturer details - Ascent Pharmaceuticals, Inc. and Camber Pharmaceuticals, Inc., along with a barcode and NDC 31722-291-10.*

FDA Label Image

137-mcg-90s (137 Mcg 90s)

Label for Levothyroxine Sodium Tablets, USP by Camber Pharmaceuticals, Inc., showing a strength of 137 mcg (0.137 mg) per tablet. The package contains 90 tablets and is marked Rx Only. The label includes storage instructions, manufacturer information for Ascent Pharmaceuticals, and notes on dispensing requirements.*

FDA Label Image

150-mcg-1000s (150 Mcg 1000s)

Label for Levothyroxine Sodium Tablets, USP 150 mcg (0.15 mg) oral tablets by Camber Pharmaceuticals, Inc. The label includes NDC 31722-292-10 and states the package contains 1000 tablets for prescription use only. Storage, handling, and manufacturing information is also provided.*

FDA Label Image

150-mcg-90s (150 Mcg 90s)

Packaging label for Levothyroxine Sodium Tablets, USP by Camber Pharmaceuticals, Inc. The label indicates a strength of 150 mcg (0.15 mg) per tablet. The package contains 90 tablets and is labeled Rx only. Storage and dispensing instructions are included, as well as manufacturer details for Ascent Pharmaceuticals, Inc. and Camber Pharmaceuticals, Inc. The label states the tablets are not varnished.*

FDA Label Image

175-mcg-1000s (175 Mcg 1000s)

Label for Levothyroxine Sodium Tablets, USP 175 mcg (0.175 mg) from Camber Pharmaceuticals, Inc. The tablet count is 1000, labeled Rx Only. The label includes storage instructions, manufacturer details (Ascent Pharmaceuticals, Inc.), and the NDC code 31722-293-10.*

FDA Label Image

175-mcg-90s (175 Mcg 90s)

Levothyroxine Sodium Tablets USP 175 mcg (0.175 mg) oral tablet label by Camber Pharmaceuticals, Inc. The label includes NDC 31722-293-90, a 90-tablet count, and states Rx only. Storage and dispensing instructions are detailed, and the label notes manufacturing by Ascent Pharmaceuticals, Inc., and Camber Pharmaceuticals, Inc.*

FDA Label Image

200-mcg-1000s (200 Mcg 1000s)

Label for Levothyroxine Sodium Tablets, USP 200 mcg (0.2 mg) by Camber Pharmaceuticals, Inc. The label indicates a quantity of 1000 tablets, prescription only. It includes storage instructions, manufacturer and labeler details, and dosage information from the USP.*

FDA Label Image

200-mcg-90s (200 Mcg 90s)

Label for Levothyroxine Sodium Tablets USP by Camber Pharmaceuticals, Inc. This label indicates a 200 mcg (0.2 mg) oral tablet, packaged in a container of 90 tablets. The label includes storage instructions, manufacturer and labeler information, and highlights that the product is prescription only (Rx Only).*

FDA Label Image

25-mcg-1000s (25 Mcg 1000s)

The label for Levothyroxine Sodium Tablets, USP 25 mcg (0.025 mg) by Camber Pharmaceuticals, Inc. It includes the NDC number 31722-284-10 and specifies a package containing 1000 tablets for oral use. Storage instructions and manufacturer details from Ascent Pharmaceuticals and Camber Pharmaceuticals are also present.*

FDA Label Image

25-mcg-90s (25 Mcg 90s)

Packaging label for Levothyroxine Sodium Tablets, USP 25 mcg (0.025 mg) by Camber Pharmaceuticals, Inc. The label states the package contains 90 oral tablets, is prescription only, and includes storage and handling instructions. It also lists manufacturing details for Ascent Pharmaceuticals, Inc. and Camber Pharmaceuticals, Inc.*

FDA Label Image

300-mcg-1000s (300 Mcg 1000s)

Label for Levothyroxine Sodium Tablets, USP 300 mcg (0.3 mg), oral tablet by Camber Pharmaceuticals, Inc. The label shows 1000 tablets in the package, with medication details including storage instructions and manufacturer information from Ascent Pharmaceuticals, Inc. and Camber Pharmaceuticals, Inc.*

FDA Label Image

300-mcg-90s (300 Mcg 90s)

Label for Levothyroxine Sodium Tablets, USP 300 mcg (0.3 mg) oral tablets by Camber Pharmaceuticals, Inc. The label indicates a package of 90 tablets, Rx only. Directions for storage and manufacturer information from Ascent Pharmaceuticals, Inc. and Camber Pharmaceuticals, Inc. are included, as well as a barcode and regulatory text.*

FDA Label Image

50-mcg-1000s (50 Mcg 1000s)

Label for Levothyroxine Sodium Tablets, USP 50 mcg (0.05 mg) oral tablets by Camber Pharmaceuticals, Inc. The package contains 1000 tablets. Storage instructions and manufacturer details for Ascent Pharmaceuticals, Inc. and Camber Pharmaceuticals, Inc. are included, along with the NDC 31722-285-10 and barcode.*

FDA Label Image

50-mcg-90s (50 Mcg 90s)

Label for Levothyroxine Sodium Tablets, USP 50 mcg (0.05 mg) by Camber Pharmaceuticals, Inc. This prescription oral tablet package contains 90 tablets. The label includes storage instructions, manufacturer information, and a barcode on the left side. The active ingredient strength is prominently displayed in a red box.*

FDA Label Image

75-mcg-1000s (75 Mcg 1000s)

Label for Levothyroxine Sodium Tablets, USP 75 mcg (0.075 mg) by Camber Pharmaceuticals, Inc. The bottle contains 1000 tablets. The label includes dosage strength, NDC 31722-286-10, manufacturer (Ascent Pharmaceuticals, Inc.), and storage instructions for the tablets in a light-resistant container. The product is Rx only.*

FDA Label Image

75-mcg-90s (75 Mcg 90s)

Label for Levothyroxine Sodium Tablets USP, 75 mcg (0.075 mg), oral tablets. The label states the package contains 90 tablets and is Rx only. It is labeled by Camber Pharmaceuticals, Inc., with the NDC 31722-286-90 and includes storage instructions and manufacturer information.*

FDA Label Image

88-mcg-1000s (88 Mcg 1000s)

Label for Levothyroxine Sodium Tablets, USP 88 mcg (0.088 mg) oral tablets. The label shows a count of 1000 tablets. It includes the NDC number 31722-287-10 and states the product is prescription-only. The labeler is Camber Pharmaceuticals, Inc., with manufacturing by Ascent Pharmaceuticals, Inc. Storage and dispensing instructions are also noted.*

FDA Label Image

88-mcg-90s (88 Mcg 90s)

Label for Levothyroxine Sodium Tablets, USP 88 mcg (0.088 mg) oral tablets by Camber Pharmaceuticals, Inc. The label indicates the package contains 90 tablets and states Rx Only. It includes storage instructions, manufacturer and labeler information, and a barcode.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of levothyroxine sodium, showing its molecular arrangement including iodine atoms, hydroxy group, and amino acid side chain.*

FDA Label Image

Table1 (Table1)

A dosing guideline table for Levothyroxine Sodium Tablets in pediatric hypothyroidism. The table lists age groups from 0-3 months to greater than 12 years with corresponding daily doses per kg body weight, ranging from 10 mcg/kg/day to 1.6 mcg/kg/day adjusted by growth and puberty status.*

FDA Label Image

Table 2 (Table2)

A data table titled 'Drugs That May Decrease T4 Absorption (Hypothyroidism)' summarizing potential interactions that may reduce the efficacy of levothyroxine sodium tablets. It lists drug classes such as Calcium Carbonate, Ferrous Sulfate, Orlistat, Bile Acid Sequestrants, Ion Exchange Resins, and other drugs like proton pump inhibitors and antacids, alongside their effects on levothyroxine absorption and recommendations for administration timing or monitoring.*

FDA Label Image

Table3 (Table3)

A data table titled 'Drugs That May Alter T4 and Triiodothyronine (T3) Serum Transport Without Affecting Free Thyroxine (FT4) Concentration (Euthyroidism).' It lists various drugs and drug classes such as clofibrate, estrogens, and salicylates, alongside their effects on serum thyroxine-binding globulin (TBG) concentration and free T4 levels. Additional notes on the potential impact of these agents when administered with levothyroxine sodium tablets are included.*

FDA Label Image

Table4 (Table4)

A data table titled 'Drugs That May Alter Hepatic Metabolism of T4 (Hypothyroidism)' describing the potential impact of enzymes stimulating hepatic metabolism leading to increased levothyroxine degradation. It lists drugs phenobarbital and rifampin, detailing their effects on levothyroxine metabolism and serum T4 levels, relevant to hypothyroidism treatment.*

FDA Label Image

Table5 (Table5)

Table listing drugs and drug classes that may decrease the conversion of T4 to T3, including beta-adrenergic antagonists, glucocorticoids, and amiodarone. The table details their potential impact on thyroid hormone levels and clinical implications.*

FDA Label Image

Table6 (Table6)

A data table listing the color additives used in levothyroxine sodium tablets by strength. It shows the microgram strengths from 25 to 300 mcg and the corresponding FD&C and D&C color additives for each dosage.*

FDA Label Image

Table7 (Table7)

A data table titled 'Pharmacokinetic Parameters of Thyroid Hormones in Euthyroid Patients' comparing levothyroxine (T4) and liothyronine (T3). It shows ratios in thyroglobulin, biologic potency, half-life (days), and protein binding percentages for the two hormones.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.